Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Add-On Titration Trial
NCT00141258Phase 3Completed
- Sponsor
- Viatris
- Start
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in focal seizures comparing Pregabalin Flexible Dose with Placebo (2 arms). Primary endpoint: Response ratio (RRatio or symmetrized percent change) for all partial seizures. Started Oct 2005; status: completed.
02
Drugs
pregabalin
03
Conditions
focal seizures
Beyond the preview
Go deeper on NCT00141258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00141258.